Manufacturing and Production

Showing 15 posts of 5862 posts found.

Switzerland first to pass EU’s ‘equivalence’ test for APIs

December 12, 2012 Manufacturing and Production API, China, EU, FMD, MHRA

Switzerland has become the first country to be classed as having equivalent standards for the manufacture of active pharmaceutical ingredients …
Roche image

Roche plans €200m investment in diagnostics facility

December 12, 2012 Manufacturing and Production Diagnostics, Roche

Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …

USP postpones work on elemental impurities

December 11, 2012 Manufacturing and Production

The US Pharmacopeial Convention (USP) has postponed the publication of new chapters on elemental impurities after an appeal by drugmakers …

Boehringer to make cancer antibody for Apexigen

December 11, 2012 Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer

Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …
EMA building

EMA sets out stall on medicine shortages

December 11, 2012 Manufacturing and Production EMA, GMP, shortages

The European Medicines Agency has called for action at the EU level to tackle the issue of medicine shortages caused …

Pharma manufacturing news in brief

December 11, 2012 Manufacturing and Production AMRI, Hovione, NextPharma Tech, Recipharm, Sanner, Solvias

AMRI renews a key contract with GE, NextPharma sells off US unit Bioserv, plus facility updates for Sanner and Recipharm …
Sanofi image

Working Life: Caroline Horwood

December 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Circassia appoints new head to its Board of directors

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
Protein image

Protein Sciences builds flu vaccine facility

December 6, 2012 Manufacturing and Production FDA, Protein

US drugmaker Protein Sciences has taken over a manufacturing facility formerly owned by Pfizer’s Wyeth unit as it prepares for …
hans_008_4189455_rohde_hans

uniQure appoints Basilea’s chief commercial officer

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
screen_shot_2012-12-05_at_10

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …

Excipient certification project moves forward

December 4, 2012 Manufacturing and Production DEG, EXCiPACT, GDP, GMP

The EXCiPACT certification scheme for pharmaceutical excipients has taken a step closer to fruition with agreements now in place with …

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …

Pharmacos ink green manufacturing pact with EU academics

December 3, 2012 Manufacturing and Production Bayer, EU, Pharmacos, Sanofi

A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …
Ranbaxy image

Ranbaxy suspends atorvastatin manufacturing after recall

November 30, 2012 Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall

Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …
The Gateway to Local Adoption Series

Latest content